Pursuant to Regulation 30(6) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that few Analysts/ Individual and Institutional Investor/ Stock Broker would be visiting Bhiwadi Plant and Meeting with the Senior Management of the Company on Saturday the 27th day of January, 2018.
The above information is a part of company’s filings submitted to BSE.